Berenberg Bank reaffirmed their buy rating on shares of NIOX Group (LON:NIOX - Free Report) in a report published on Tuesday, MarketBeat.com reports. They currently have a GBX 90 ($1.20) price target on the stock.
NIOX Group Price Performance
Shares of NIOX traded down GBX 0.23 ($0.00) during mid-day trading on Tuesday, reaching GBX 58.77 ($0.78). The company had a trading volume of 261,593 shares, compared to its average volume of 1,104,655. The company's 50 day simple moving average is GBX 65.48 and its 200 day simple moving average is GBX 63.80. The company has a market capitalization of £24.14 billion, a price-to-earnings ratio of 2,425.50 and a beta of 0.92. NIOX Group has a 1-year low of GBX 53.40 ($0.71) and a 1-year high of GBX 80 ($1.06). The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31.
NIOX Group (LON:NIOX - Get Free Report) last announced its quarterly earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. Analysts expect that NIOX Group will post 1.1658256 EPS for the current year.
Insider Transactions at NIOX Group
In other NIOX Group news, insider Jonathan Emms acquired 127,454 shares of NIOX Group stock in a transaction that occurred on Tuesday, April 1st. The shares were bought at an average price of GBX 8 ($0.11) per share, with a total value of £10,196.32 ($13,557.13). Company insiders own 46.72% of the company's stock.
NIOX Group Company Profile
(
Get Free Report)
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Read More
Before you consider NIOX Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIOX Group wasn't on the list.
While NIOX Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
